Blood plasma reduces risk of severe COVID-19 if given early

They arrive nearly five months after the Food and Drug Administration, under pressure from President Donald Trump, issued the therapy an emergency green light for use in people hospitalized with COVID-19.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2JRsgG1
via IFTTT